Back
ProQR Therapeutics NV Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
10
PRQR
ProQR Therapeutics NV
Last Price:
$2.65
Seasonality Move:
2.98%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ProQR Therapeutics NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.84 | Sell |
| 20-day SMA: | 3.28 | Sell |
| 50-day SMA: | 3.39 | Sell |
| 200-day SMA: | 2.31 | Buy |
| 8-day EMA: | 2.83 | Sell |
| 20-day EMA: | 3.13 | Sell |
| 50-day EMA: | 3.13 | Sell |
| 200-day EMA: | 2.49 | Buy |
ProQR Therapeutics NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 37.54 | Sell |
| Chaikin Money Flow: | 309315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.95 - 3.77) | Sell |
| Bollinger Bands (100): | (1.8 - 3.5) | Buy |
ProQR Therapeutics NV Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProQR Therapeutics NV Stock
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 2.66 while PRQR 8-day simple moving average is 2.84, which is a Sell signal.
-
The stock price of PRQR is 2.66 while ProQR Therapeutics NV 20-day SMA is 3.28, which makes it a Sell.
-
ProQR Therapeutics NV 50-day simple moving average is 3.39 while PRQR share price is 2.66, making it a Sell technically.
-
PRQR stock price is 2.66 and ProQR Therapeutics NV 200-day simple moving average is 2.31, creating a Buy signal.
PRQR Technical Analysis vs Fundamental Analysis
Sell
10
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a SellThe current ProQR Therapeutics NV [PRQR] share price is $2.66. The Score for PRQR is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
ProQR Therapeutics NV Stock Info
Market Cap:
281.2M
Price in USD:
2.66
Share Volume:
547.3K
ProQR Therapeutics NV 52-Week Range
52-Week High:
4.62
52-Week Low:
1.61
Sell
10
ProQR Therapeutics NV (PRQR)
is a Sell
ProQR Therapeutics NV Share Price Forecast
-
What is the ProQR Therapeutics NV stock price today?The ProQR Therapeutics NV stock price is 2.66 USD today.
-
Will PRQR stock go up or go down?ProQR Therapeutics NV> share price is forecast to RISE/FALL based on technical indicators
-
Is ProQR Therapeutics NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProQR Therapeutics NV is overvalued.
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 2.66 while PRQR 8-day exponential moving average is 2.83, which is a Sell signal.
-
The stock price of PRQR is 2.66 while ProQR Therapeutics NV 20-day EMA is 3.13, which makes it a Sell.
-
ProQR Therapeutics NV 50-day exponential moving average is 3.13 while PRQR share price is 2.66, making it a Sell technically.
-
PRQR stock price is 2.66 and ProQR Therapeutics NV 200-day simple moving average is 2.49, creating a Buy signal.
Fundamental Analysis of ProQR Therapeutics NV
Is ProQR Therapeutics NV a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.07 per share.
Technical Analysis of ProQR Therapeutics NV
Should I short ProQR Therapeutics NV stock?
-
PRQR Moving Average Covergence Divergence (MACD) indicator is -0.22, suggesting ProQR Therapeutics NV is a Sell
-
ProQR Therapeutics NV Relative Strength Index (RSI) is 37.54, which suggest ProQR Therapeutics NV is oversold
-
The Bollinger Bands (25) for ProQR Therapeutics NV is (2.95 - 3.77), which suggest ProQR Therapeutics NV is a Buy
-
The Bollinger Bands (100) for ProQR Therapeutics NV is (1.8 - 3.5), which suggest ProQR Therapeutics NV is a Buy
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.